Vasista A - Search Results

1

Survival and cardiac toxicity in patients with HER2-positive, metastatic breast cancer treated with trastuzumab in routine clinical practice.

Vasista A, Ryan L, Naher S, Moylan E, Stockler MR, Wilcken N, Kiely BE. Vasista A, et al. Asia Pac J Clin Oncol. 2020 Feb;16(1):34-38. doi: 10.1111/ajco.13280. Epub 2019 Oct 28. Asia Pac J Clin Oncol. 2020. PMID: 31657878

2

More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials.

Vasista A, Stockler MR, West T, Wilcken N, Kiely BE. Vasista A, et al. Breast. 2017 Feb;31:99-104. doi: 10.1016/j.breast.2016.10.007. Epub 2016 Nov 6. Breast. 2017. PMID: 27829202

3

Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.

Vasista A, Stockler M, Martin A, Pavlakis N, Sjoquist K, Goldstein D, Gill S, Jain V, Liu G, Kannourakis G, Kim YH, Nott L, Snow S, Burge M, Harris D, Jonker D, Chua YJ, Epstein R, Bonaventura A, Kiely B. Vasista A, et al. Oncologist. 2019 Nov;24(11):e1102-e1107. doi: 10.1634/theoncologist.2018-0613. Epub 2019 Apr 1. Oncologist. 2019. PMID: 30936377 Free PMC article. Clinical Trial.

4

Communicating prognostic information: what do oncologists think patients with incurable cancer should be told?

Vasista A, Stockler MR, Martin A, Lawrence NJ, Kiely BE. Vasista A, et al. Intern Med J. 2020 Dec;50(12):1492-1499. doi: 10.1111/imj.14739. Intern Med J. 2020. PMID: 31904887

5

Accuracy of oncologists' estimates of expected survival time in advanced cancer.

Nahm SH, Martin AJ, Clayton JM, Grimison P, Moth EB, Pavlakis N, Sjoquist K, Smith-Uffen MES, Tognela A, Vasista A, Stockler MR, Kiely BE. Nahm SH, et al. Among authors: vasista a. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad094. doi: 10.1093/jncics/pkad094. JNCI Cancer Spectr. 2023. PMID: 37963058 Free PMC article.

6

Molecular Strong Coupling and Cavity Finesse.

Menghrajani KS, Vasista AB, Tan WJ, Thomas PA, Herrera F, Barnes WL. Menghrajani KS, et al. Among authors: vasista ab. J Phys Chem Lett. 2024 Jul 25;15(29):7449-7457. doi: 10.1021/acs.jpclett.4c00782. Epub 2024 Jul 15. J Phys Chem Lett. 2024. PMID: 39008808 Free PMC article.

7

Beyond the median: Estimating survival times for patients starting endocrine therapy for estrogen receptor-positive, metastatic breast cancer from recent randomized trials.

Parsonson AO, Sarkar S, Brown L, Low GKK, Kiely BE, Vasista A. Parsonson AO, et al. Among authors: vasista a. Asia Pac J Clin Oncol. 2024 Dec;20(6):714-722. doi: 10.1111/ajco.14096. Epub 2024 Jun 16. Asia Pac J Clin Oncol. 2024. PMID: 38881159

8

Coronary Flow Velocity Reserve Declines After Anthracycline Therapy in Breast Cancer Patients.

Yu C, Jeyaprakash P, Ozawa K, Negishi T, Sabanathan D, Park J, Man J, Vasista A, Pathan F, Negishi K. Yu C, et al. Among authors: vasista a. CJC Open. 2024 Feb 3;6(5):768-772. doi: 10.1016/j.cjco.2024.01.009. eCollection 2024 May. CJC Open. 2024. PMID: 38846439 Free PMC article.

9

Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy.

Smith-Uffen M, Park J, Parsonson A, Kiely BE, Vasista A. Smith-Uffen M, et al. Among authors: vasista a. Oncologist. 2024 Nov 4;29(11):922-930. doi: 10.1093/oncolo/oyae089. Oncologist. 2024. PMID: 38768122 Free PMC article.

10

Non-steady state thermometry with optical diffraction tomography.

Vasista AB, Ciraulo B, Schmidt F, Arroyo JO, Quidant R. Vasista AB, et al. Sci Adv. 2024 Mar 22;10(12):eadk5440. doi: 10.1126/sciadv.adk5440. Epub 2024 Mar 22. Sci Adv. 2024. PMID: 38517963 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters